Literature DB >> 16877227

Persistent hyperinsulinaemic hypoglycaemia of infancy in 43 children: long-term clinical and surgical follow-up.

Saleh Al-Nassar1, Nadia Sakati, Abdullah Al-Ashwal, Bassam Bin-Abbas.   

Abstract

OBJECTIVE: To describe the clinical, surgical, biochemical, radiological and electrophysiological features of 43 Saudi children with persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) who have been followed since 1983.
METHODS: Data from 43 patients were retrospectively analysed. PHHI was diagnosed on the basis of high intravenous glucose requirement, high insulin to glucose ratio, negative urinary ketones and normal tandem mass spectrometry. The patients were assessed radiologically by brain magnetic resonance imaging and/or computed tomography and electrophysiologically by brain stem auditory evoked potential, visual evoked response and electroencephalogram. Patients who failed medical therapy received near total pancreatectomy.
RESULTS: The patients were severely hypoglycaemic and intolerant to fast. Hypoglycaemic convulsion was the most commonly presenting complaint. Eighteen patients were developmentally delayed and 14 of them had brain atrophy. All patients, except nine, did not respond to medical treatment and underwent surgery. Four pancreatectomized patients developed diabetes and two had malabsorption. One baby had 180 cm resection of gangrenous bowel most likely secondary to octreotide. No common bile duct injury was encountered. One patient was treated medically during childhood and developed diabetes and gained weight during adolescence.
CONCLUSION: PHHI is a relatively common and serious disease among Saudi children. Early intervention is necessary to avoid neurological damage in patients who are severely hypoglycaemic and unresponsive to medical therapy. Surgically and probably medically treated patients are at a high risk of developing diabetes, which could be the natural outcome of this disease. Care and spending time during surgery to visualize the common bile duct help in avoiding its injury.

Entities:  

Mesh:

Year:  2006        PMID: 16877227     DOI: 10.1016/S1015-9584(09)60089-0

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  8 in total

1.  A Case Series: Congenital Hyperinsulinism.

Authors:  Mohammad Reza Alaei; Susan Akbaroghli; Mohammad Keramatipour; Ali Alaei
Journal:  Int J Endocrinol Metab       Date:  2016-09-10

2.  Both Low Blood Glucose and Insufficient Treatment Confer Risk of Neurodevelopmental Impairment in Congenital Hyperinsulinism: A Multinational Cohort Study.

Authors:  Annett Helleskov; Maria Melikyan; Evgenia Globa; Inna Shcherderkina; Fani Poertner; Anna-Maria Larsen; Karen Filipsen; Klaus Brusgaard; Charlotte Dahl Christiansen; Lars Kjaersgaard Hansen; Henrik T Christesen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-10       Impact factor: 5.555

Review 3.  Congenital Hyperinsulinism in China: A Review of Chinese Literature Over the Past 15 Years.

Authors:  Wei Yan Wang; Yi Sun; Wen Ting Zhao; Tai Wu; Liang Wang; Tian Ming Yuan; Hui Min Yu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-03-08

4.  Clinical characteristics and phenotype-genotype review of 25 Omani children with congenital hyperinsulinism in infancy. A one-decade single-center experience.

Authors:  Maryam K Al-Badi; Hanan S Al-Azkawi; Mouza S Al-Yahyaei; Waad A Mula-Abed; Aisha M Al-Senani
Journal:  Saudi Med J       Date:  2019-07       Impact factor: 1.484

5.  Altered Serum Amino Acid and Acylcarnitine Profiles in Hyperinsulinemic Hypoglycemia and Ketotic Hypoglycemia.

Authors:  Zhen-Ran Xu; Xiao-Yi Zhu; Wei Lu; Wei-Hua Sun; Ruo-Qian Cheng; Jin-Wen Ni; Li Xi; Khalid Hussain; Fei-Hong Luo; Miao-Ying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-08       Impact factor: 5.555

Review 6.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

Review 7.  Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Authors:  Alena Welters; Christian Lerch; Sebastian Kummer; Jan Marquard; Burak Salgin; Ertan Mayatepek; Thomas Meissner
Journal:  Orphanet J Rare Dis       Date:  2015-11-25       Impact factor: 4.123

8.  Long-Term Outcome and Treatment in Persistent and Transient Congenital Hyperinsulinism: A Finnish Population-Based Study.

Authors:  Jonna M E Männistö; Jarmo Jääskeläinen; Timo Otonkoski; Hanna Huopio
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.